Hensley Mark Earl
Reporting owner on Forms 3, 4 and 5, CIK 2065816.
Hensley Mark Earl reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-10.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| HRTX · HERON THERAPEUTICS, INC. /DE/CIK 818033 | officer (Chief Operating Officer) | 2 | 2026-11-10 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| HRTX · HERON THERAPEUTICS, INC. /D…Common Stock | 2026-11-06 | M exercised | +31,250 | 210,572 | Form 4 | |
| HRTX · HERON THERAPEUTICS, INC. /D…Common Stock | 2026-11-06 | F withheld for tax | -8,889 | $0.29 | 201,683 | Form 4 |
| HRTX · HERON THERAPEUTICS, INC. /D…Restricted Stock Units, derivative | 2026-11-06 | M exercised | -31,250 | $0 | 312,500 | Form 4 |
| HRTX · HERON THERAPEUTICS, INC. /D…Common Stock | 2026-10-30 | M exercised | +11,770 | 182,671 | Form 4 | |
| HRTX · HERON THERAPEUTICS, INC. /D…Common Stock | 2026-10-30 | F withheld for tax | -3,349 | $0.28 | 179,322 | Form 4 |
| HRTX · HERON THERAPEUTICS, INC. /D…Restricted Stock Units, derivative | 2026-10-30 | M exercised | -11,770 | $0 | 153,006 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-454742 | HERON THERAPEUTICS, INC. /DE/ | 2026-11-10 | ||
| Form 4 0001193125-26-444831 | HERON THERAPEUTICS, INC. /DE/ | 2026-11-03 |